The DOI matches its Crossref record; 466 of the 466 references it cites were found in a registry or an index.
Nanovehicular Intracellular Delivery Systems
Open accessAbstract
This article provides an overview of principles and barriers relevant to intracellular drug and gene transport, accumulation and retention (collectively called as drug delivery) by means of nanovehicles (NV). The aim is to deliver a cargo to a particular intracellular site, if possible, to exert a local action. Some of the principles discussed in this article apply to noncolloidal drugs that are not permeable to the plasma membrane or to the blood–brain barrier. NV are defined as a wide range of nanosized particles leading to colloidal objects which are capable of entering cells and tissues and delivering a cargo intracelullarly. Different localization and targeting means are discussed. Limited discussion on pharmacokinetics and pharmacodynamics is also presented. NVs are contrasted to micro-delivery and current nanotechnologies which are already in commercial use. Newer developments in NV technologies are outlined and future applications are stressed. We also briefly review the existing modeling tools and approaches to quantitatively describe the behavior of targeted NV within the vascular and tumor compartments, an area of particular importance. While we list “elementary” phenomena related to different level of complexity of delivery to cancer, we also stress importance of multi-scale modeling and bottom-up systems biology approach.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 466
Gene transfer with modified polyethylenimines
Kichler, A. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.507 · Cited by 265
Intracellular trafficking pathways and drug delivery: fluorescence imaging of living and fixed cells
WATSON, P. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.05.003 · Cited by 265
Nafee, N., Taetz, S., Schneider, M., Schaefer, U. F., & Lehr, C.-M. (2007) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2007.03.006 · Cited by 264
In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma.
de Menezes, D. E. L., Pilarski, L. M., & Allen, T. M. (1998) · PubMed · Cited by 257
Senior, J., Crawley, J. C. W., & Gregoriadis, G. (1985) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(85)90174-6 · Cited by 253
Analytical model of magnetic nanoparticle transport and capture in the microvasculature
Furlani, E. P., & Ng, K. C. (2006) · Physical Review E · doi:10.1103/physreve.73.061919 · Cited by 250
Target-mediated drug disposition and dynamics
Mager, D. E. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.12.041 · Cited by 244
Sapra, P., & Allen, T. M. (2002) · PubMed · Cited by 242
Lee, K.-D., Hong, K., & Papahadjopoulos, D. (1992) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(92)90086-2 · Cited by 240
Clathrin‐Dependent or Not: Is It Still the Question?
Johannes, L., & Lamaze, C. (2002) · Traffic · doi:10.1034/j.1600-0854.2002.30701.x · Cited by 239
Active targeting with particulate drug carriers in tumor therapy: fundamentals and recent progress
Marcucci, F., & Lefoulon, F. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02988-x · Cited by 236
Tousignant, J. D., Gates, A. L., Ingram, L. A., Johnson, C. L., Nietupski, J. B., Cheng, S. H., Eastman, S. J., & Scheule, R. K. (2000) · Human Gene Therapy · doi:10.1089/10430340050207984 · Cited by 236
Near-Infrared Fluorescent RGD Peptides for Optical Imaging of Integrin αvβ3Expression in Living Mice
Cheng, Z., Wu, Y., Xiong, Z., Gambhir, S. S., & Chen, X. (2005) · Bioconjugate Chemistry · doi:10.1021/bc0501698 · Cited by 234
Measurement of endosome pH following folate receptor-mediated endocytosis
Lee, R. J., Wang, S., & Low, P. S. (1996) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(96)00041-9 · Cited by 232
Integrin targeting using RGD‐PEI conjugates for in vitro gene transfer
Kunath, K., Merdan, T., Hegener, O., Häberlein, H., & Kissel, T. (2003) · The Journal of Gene Medicine · doi:10.1002/jgm.382 · Cited by 231
Galindo-Rodriguez, S. A., Allemann, E., Fessi, H., & Doelker, E. (2005) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v22.i5.10 · Cited by 231
Liposomal malaria vaccine in humans: a safe and potent adjuvant strategy.
Fries, L. F., Gordon, D. M., Richards, R. L., Egan, J. E., Hollingdale, M. R., Gross, M., Silverman, C., & Alving, C. R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.1.358 · Cited by 228
Song, L. Y., Ahkong, Q. F., Rong, Q., Wang, Z., Ansell, S., Hope, M. J., & Mui, B. (2002) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00399-6 · Cited by 228
A dual-ligand approach for enhancing targeting selectivity of therapeutic nanocarriers
Saul, J. M., Annapragada, A. V., & Bellamkonda, R. V. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.05.028 · Cited by 227
Mechanistic aspects of CPP-mediated intracellular drug delivery: Relevance of CPP self-assembly
Pujals, S., Fernández-Carneado, J., López-Iglesias, C., Kogan, M. J., & Giralt, E. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.01.006 · Cited by 223
Controlled Drug Release from Porous Polyelectrolyte Multilayers
Berg, M. C., Zhai, L., Cohen, R. E., & Rubner, M. F. (2006) · Biomacromolecules · doi:10.1021/bm050174e · Cited by 223
Huth, U. S., Schubert, R., & Peschka-Süss, R. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.10.018 · Cited by 221
Calcium phosphate nanoparticles: second-generation nonviral vectors in gene therapy
Maitra, A. (2005) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.5.6.893 · Cited by 219
The power of the pump: Mechanisms of action of P-glycoprotein (ABCB1)
Ambudkar, S. V., Kim, I.-W., & Sauna, Z. E. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.10.010 · Cited by 217
Effect of dose on the biodistribution and pharmacokinetics of PLGA and PLGA-mPEG nanoparticles
Panagi, Z., Beletsi, A., Evangelatos, G., Livaniou, E., Ithakissios, D. S., & Avgoustakis, K. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00676-7 · Cited by 215
Awasthi, V., Garcia, D., Goins, B., & Phillips, W. T. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00703-2 · Cited by 215
Recombinant lipoproteins: lipoprotein-like lipid particles for drug targeting
Rensen, P. C. N., de Vrueh, R. L. A., Kuiper, J., Bijsterbosch, M. K., Biessen, E. A. L., & van Berkel, T. J. C. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00109-0 · Cited by 215
HER2 Specific Tumor Targeting with Dendrimer Conjugated Anti-HER2 mAb
Shukla, R., Thomas, T. P., Peters, J. L., Desai, A. M., Kukowska-Latallo, J., Patri, A. K., Kotlyar, A., & Baker, J. R. (2006) · Bioconjugate Chemistry · doi:10.1021/bc050348p · Cited by 213
Bertorelle, F., Wilhelm, C., Roger, J., Gazeau, F., Ménager, C., & Cabuil, V. (2006) · Langmuir · doi:10.1021/la052710u · Cited by 211
Quantitative analysis of the endocytic system involved in hormone-induced receptor internalization.
Lund, K. A., Opresko, L. K., Starbuck, C., Walsh, B. J., & Wiley, H. S. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55456-9 · Cited by 210
Gene Transfer by Means of Lipo- and Polyplexes: Role of Clathrin and Caveolae-Mediated Endocytosis
Rejman, J., Conese, M., & Hoekstra, D. (2006) · Journal of Liposome Research · doi:10.1080/08982100600848819 · Cited by 207
Graff, C. P., & Wittrup, K. D. (2003) · PubMed · Cited by 205
Goldberg, E. P., Hadba, A. R., Almond, B. A., & Marotta, J. S. (2002) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357021778268 · Cited by 203
Intracellular Barriers to Non-Viral Gene Transfer
Lechardeur, D., & Lukacs, G. (2002) · Current Gene Therapy · doi:10.2174/1566523024605609 · Cited by 203
Bazile, D. V., Ropert, C., Huve, P., Verrecchia, T., Mariard, M., Frydman, A., Veillard, M., & Spenlehauer, G. (1992) · Biomaterials · doi:10.1016/0142-9612(92)90142-b · Cited by 200
Garcion, E., Lamprecht, A., Heurtault, B., Paillard, A., Aubert-Pouessel, A., Denizot, B., Menei, P., & Benoît, J.-P. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0289 · Cited by 198
Kirkham, M., & Parton, R. G. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2005.11.005 · Cited by 197
Cell-specific nuclear import of plasmid DNA
Vacik, J., Dean, B. S., Zimmer, W. E., & Dean, D. A. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300924 · Cited by 197
Endocytosis of folate-protein conjugates: ultrastructural localization in kb cells
Turek, J. J., & Low, P. S. (1993) · Journal of Cell Science · doi:10.1242/jcs.106.1.423 · Cited by 196
Sumimoto, H., Miyagishi, M., Miyoshi, H., Yamagata, S., Shimizu, A., Taira, K., & Kawakami, Y. (2004) · Oncogene · doi:10.1038/sj.onc.1207812 · Cited by 194
Koukourakis, M. I., Koukouraki, S., Giatromanolaki, A., Archimandritis, S. C., Skarlatos, J., Beroukas, K., Bizakis, J. G., Retalis, G., Karkavitsas, N., & Helidonis, E. S. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.11.3512 · Cited by 191
Targeting cancer micrometastases with monoclonal antibodies: a binding-site barrier.
Saga, T., Neumann, R. D., Heya, T., Sato, J., Kinuya, S., Le, N., Paik, C. H., & Weinstein, J. N. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.19.8999 · Cited by 191
Nanomedicine: Clinical Applications of Polyethylene Glycol Conjugated Proteins and Drugs
Parveen, S., & Sahoo, S. K. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645100-00002 · Cited by 189
A multiscale mathematical model of cancer, and its use in analyzing irradiation therapies
Ribba, B., Colin, T., & Schnell, S. (2006) · Theoretical Biology and Medical Modelling · doi:10.1186/1742-4682-3-7 · Cited by 188
Simões, S., Slepushkin, V, Gaspar, R., Pedroso de Lima, M., & Düzgüneş, N. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300674 · Cited by 186
Ruiz, F. E., Clancy, J. P., Perricone, M. A., Bebok, Z., Hong, J. S., Cheng, S. H., Meeker, D. P., Young, K. R., Schoumacher, R. A., Weatherly, M. R., et al. (2001) · Human Gene Therapy · doi:10.1089/104303401750148667 · Cited by 185
Hawley, A. E., Davis, S. S., & Illum, L. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00045-9 · Cited by 183
Balakin, K., Savchuk, N., & Tetko, I. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706775197917 · Cited by 183
Advanced Drug Delivery Systems That Target The Vascular Endothelium
Ding, B.-S. (2006) · Molecular Interventions · doi:10.1124/mi.6.2.7 · Cited by 182
Miglietta, A., Cavalli, R., Bocca, C., Gabriel, L., & Rosa Gasco, M. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00562-7 · Cited by 180
Ligand-Receptor-Mediated Drug Delivery: An Emerging Paradigm in Cellular Drug Targeting
Vyas, S. P., Singh, A., & Sihorkar, V. (2001) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v18.i1.10 · Cited by 180
Targeting of stealth liposomes to erbB-2 (Her/2) receptor: in vitro and in vivo studies
Goren, D., Horowitz, A., Zalipsky, S., Woodle, M., Yarden, Y., & Gabizon, A. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.625 · Cited by 179
Liposomal drug delivery systems--clinical applications.
Goyal, P., Goyal, K., Kumar, S. G. V., Singh, A., Katare, O. P., & Mishra, D. N. (2005) · PubMed · Cited by 178
Carbon nanotubes for the delivery of therapeutic molecules
Bianco, A. (2004) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.1.1.57 · Cited by 176
Molecular Targeting of Drug Delivery Systems to Cancer
Minko, T., Dharap, S., Pakunlu, R., & Wang, Y. (2004) · Current Drug Targets · doi:10.2174/1389450043345443 · Cited by 175
Klapper, L. N., Vaisman, N., Hurwitz, E., Pinkas-Kramarski, R., Yarden, Y., & Sela, M. (1997) · Oncogene · doi:10.1038/sj.onc.1201029 · Cited by 174
Liposome-based approaches to overcome anticancer drug resistance
Mamot, C., Drummond, D. C., Hong, K., Kirpotin, D. B., & Park, J. W. (2003) · Drug Resistance Updates · doi:10.1016/s1368-7646(03)00082-7 · Cited by 170
Selective targeting of cancer cells using synthetic peptides
Shadidi, M., & Sioud, M. (2003) · Drug Resistance Updates · doi:10.1016/j.drup.2003.11.002 · Cited by 170
de Verdière, A., Dubernet, C., Némati, F., Soma, E., Appel, M., Ferté, J., Bernard, S., Puisieux, F., & Couvreur, P. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.362 · Cited by 168
Origin, originality, functions, subversions and molecular signalling of macropinocytosis
Amyere, M., Mettlen, M., Van Der Smissen, P., Platek, A., Payrastre, B., Veithen, A., & Courtoy, P. J. (2001) · International Journal of Medical Microbiology · doi:10.1078/1438-4221-00157 · Cited by 167
Quantification of information transfer via cellular signal transduction pathways
(1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01018-1 · Cited by 166
Reversible Covalent Chemistry in Drug Delivery
West, K., & Otto, S. (2005) · Current Drug Discovery Technologies · doi:10.2174/1570163054866882 · Cited by 166
NLS bioconjugates for targeting therapeutic genes to the nucleus
Escriou, V., Carrière, M., Scherman, D., & Wils, P. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00184-9 · Cited by 164
Role of endocytosis in the transfection of L929 fibroblasts by polyethylenimine/DNA complexes
Rémy-Kristensen, A., Clamme, J.-P., Vuilleumier, C., Kuhry, J.-G., & Mély, Y. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00359-5 · Cited by 162
Mechanisms of cellular uptake of long chain free fatty acids
Berk, P. D., & Stump, D. D. (1999) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006832001033 · Cited by 161
Would near-infrared fluorescence signals propagate through large human organs for clinical studies?
Ntziachristos, V., Ripoll, J., & Weissleder, R. (2002) · Optics Letters · doi:10.1364/ol.27.000333 · Cited by 161
Trubetskoy, V. S., Wong, S. C., Subbotin, V, Budker, V. G., Loomis, A., Hagstrom, J. E., & Wolff, J. A. (2003) · Gene Therapy · doi:10.1038/sj.gt.3301888 · Cited by 161
Jiang, Y.-H., Emau, P., Cairns, J. S., Flanary, L., Morton, W. R., McCarthy, T. D., & Tsai, C.-C. (2005) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2005.21.207 · Cited by 160
Clathrin-independent endocytosis: new insights into caveolae and non-caveolar lipid raft carriers.
Kirkham, M., & Parton, R. (2005) · Biochimica et Biophysica Acta · doi:10.1016/j.bbamcr.2005.11.007 · Cited by 159
Nanoparticles for Cellular Drug Delivery: Mechanisms and Factors Influencing Delivery
Chavanpatil, M. D., Khdair, A., & Panyam, J. (2006) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2006.443 · Cited by 158
Metallic Colloid Nanotechnology, Applications in Diagnosis and Therapeutics
Sonvico, F., Dubernet, C., Colombo, P., & Couvreur, P. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612054065738 · Cited by 158
Iterative approach to model identification of biological networks
Gadkar, K. G., Gunawan, R., & Doyle, F. J. (2005) · BMC Bioinformatics · doi:10.1186/1471-2105-6-155 · Cited by 155
Muro, S., Cui, X., Gajewski, C., Murciano, J.-C., Muzykantov, V. R., & Koval, M. H. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00099.2003 · Cited by 153
Kattan, J. G., Droz, J., Couvreur, P., Marino, J. P., Boutan-Laroze, A., Rougier, P. R., Brault, P., Vranckx, H., Grognet, J., Morge, X., et al. (1992) · Investigational New Drugs · doi:10.1007/bf00877245 · Cited by 153
Targets for pharmacological intervention of endothelial hyperpermeability and barrier function
Amerongen, G. P. V. N., & van Hinsbergh, V. W. M. (2002) · Vascular Pharmacology · doi:10.1016/s1537-1891(03)00014-4 · Cited by 152
Multifunctional Nanoparticulate Polyelectrolyte Complexes
Hartig, S. M., Greene, R. R., Dikov, M. M., Prokop, A., & Davidson, J. M. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9459-1 · Cited by 151
Self-citationHurwitz, E., Stancovski, I., Sela, M., & Yarden, Y. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.8.3353 · Cited by 148
Signal amplification in molecular imaging by pretargeting a multivalent, bispecific antibody
Sharkey, R. M., Cardillo, T. M., Rossi, E. A., Chang, C., Karacay, H., McBride, W. J., Hansen, H. J., Horak, I. D., & Goldenberg, D. M. (2005) · Nature Medicine · doi:10.1038/nm1322 · Cited by 148
Finsinger, D., Remy, J.-S., Erbacher, P., Koch, C., & Plank, C. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301227 · Cited by 148
Hatakeyama, H., Akita, H., Maruyama, K., Suhara, T., & Harashima, H. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.05.025 · Cited by 147
Reddy, S. T., Berk, D. A., Jain, R. K., & Swartz, M. A. (2006) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00389.2006 · Cited by 145
Saupe, A., Wissing, S. A., Lenk, A., Schmidt, C., & Müller, R. H. (2005) · PubMed · Cited by 144
Dendrimer-Based Nanosized MRI Contrast Agents
Kobayashi, H., & Brechbiel, M. W. (2004) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201043376571 · Cited by 144
Baxter, L. T., & Jain, R. K. (1991) · Microvascular Research · doi:10.1016/0026-2862(91)90026-8 · Cited by 144
Brown, M. D., Schätzlein, A. G., Brownlie, A., Jack, V., Wang, W., Tetley, L., GRAY, A. I., & Uchegbu, I. F. (2000) · Bioconjugate Chemistry · doi:10.1021/bc000052d · Cited by 141
Adaptation of inorganic quantum dots for stable molecular beacons
Kim, J. H., Morikis, D., & Ozkan, M. (2004) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2004.04.107 · Cited by 139
Biodegradable Nanoparticles for Direct or Two-Step Tumor Immunotargeting
Bossy-Nobs, L., Buchegger, F., Gurny, R., & Allémann, É. (2005) · Bioconjugate Chemistry · doi:10.1021/bc050137k · Cited by 139
In Vivo Tomographic Imaging of Near-Infrared Fluorescent Probes
Ntziachristos, V., Bremer, C., Graves, E. E., Ripoll, J., & Weissleder, R. (2002) · Molecular Imaging · doi:10.1162/153535002320162732 · Cited by 139
Kasturi, S. P., Sachaphibulkij, K., & Roy, K. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.03.043 · Cited by 138
The role of apolipoprotein E in the elimination of liposomes from blood by hepatocytes in the mouse
Yan, X., Kuipers, F., Havekes, L. M., Havinga, R., Dontje, B., Poelstra, K., Scherphof, G. L., & Kamps, J. A. A. M. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.12.137 · Cited by 138
Kostarelos, K. (2003) · Advances in Colloid and Interface Science · doi:10.1016/s0001-8686(03)00109-x · Cited by 138
Physical Chemical Considerations of Lipid-Based Oral Drug Delivery-Solid Lipid Nanoparticles
Bummer, P. M. (2004) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v21.i1.10 · Cited by 137
In Vivo Phage Display Selection Yields Atherosclerotic Plaque Targeted Peptides for Imaging
Kelly, K. A., Nahrendorf, M., Yu, A. M., Reynolds, F., & Weissleder, R. (2006) · Molecular Imaging and Biology · doi:10.1007/s11307-006-0043-6 · Cited by 136
Moghimi, S. M. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00099-4 · Cited by 135
Ojeda, R., de Paz, J. L., Barrientos, Á. G., Martín‐Lomas, M., & Penadés, S. (2006) · Carbohydrate Research · doi:10.1016/j.carres.2006.11.018 · Cited by 133
Modeling of Drug Release from Polymeric Delivery Systems?A Review;
Lopina, S. T., & Kanjickal, D. (2004) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v21.i5.10 · Cited by 133
Gene delivery by dendrimers operates via a cholesterol dependent pathway
Manunta, M., Tan, P., Sagoo, P., Kashefi, K., & George, A. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh595 · Cited by 133
Albumin Nanoparticles for the Intravitreal Delivery of Anticytomegaloviral Drugs
Irache, J. M., Merodio, M., Arnedo, A., Camapanero, M., Mirshahi, M., & Espuelas, S. (2005) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557053175335 · Cited by 131
Lin, E. E., & Nemunaitis, J. J. (2004) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700733 · Cited by 130
Prabha, S., & Labhasetwar, V. D. (2004) · Molecular Pharmaceutics · doi:10.1021/mp049970+ · Cited by 128
Binding and interstitial penetration of liposomes within avascular tumor spheroids
Kostarelos, K., Emfietzoglou, D., Papakostas, A., Yang, W., Ballangrud, Å., & Sgouros, G. (2004) · International Journal of Cancer · doi:10.1002/ijc.20457 · Cited by 127
A new synthesis of galactose-poly(ethylene glycol)-polyethylenimine for gene delivery to hepatocytes
SAGARA, K. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00555-7 · Cited by 127
Fernández‐Carneado, J., Gool, M. V., Martos, V., Castel, S., Prados, P., de Mendoza, J., & Giralt, E. (2004) · Journal of the American Chemical Society · doi:10.1021/ja044006q · Cited by 125
Reduction of surface-induced inflammatory reaction on PLGA/MPC polymer blend
Iwasaki, Y., Sawada, S., Ishihara, K., Khang, G., & Lee, H. B. (2002) · Biomaterials · doi:10.1016/s0142-9612(02)00135-7 · Cited by 123
Zeng, Y., Tao, N., Chung, K.-N., Heuser, J. E., & Lublin, D. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307722200 · Cited by 122
Endothelial Endocytic Pathways: Gates for Vascular Drug Delivery
Muro, S., Koval, M. H., & Muzykantov, V. R. (2004) · Current Vascular Pharmacology · doi:10.2174/1570161043385736 · Cited by 122
Targeted induction of apoptosis for cancer therapy: current progress and prospects
Bremer, E., van Dam, G., Kroesen, B. J., de Leij, L., & Helfrich, W. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.06.002 · Cited by 121
Enhanced heparan sulfate proteoglycan-mediated uptake of cell-penetrating peptide-modified liposomes
Marty, C., Meylan, C., Schott, H. N., Ballmer‐Hofer, K., & Schwendener, R. A. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4166-0 · Cited by 121
Mathematical modelling of radiotherapy strategies for early breast cancer
Enderling, H., Anderson, A. R. A., Chaplain, M. A. J., Munro, A. J., & Vaidya, J. S. (2005) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2005.11.015 · Cited by 120
Mathematical modeling of cancer: The future of prognosis and treatment
Quaranta, V., Weaver, A. M., Cummings, P. T., & Anderson, A. R. A. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2005.03.023 · Cited by 119
Understanding carbohydrate-carbohydrate Interactions by means of glyconanotechnology
de la Fuente, J. M., & Penadés, S. (2004) · Glycoconjugate Journal · doi:10.1023/b:glyc.0000044846.80014.cb · Cited by 119
Regulatory Dynamics of Synthetic Gene Networks with Positive Feedback
Maeda, Y. T., & Sano, M. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.03.064 · Cited by 119
From Conventional to Stealth Liposomes: a New Frontier in Cancer Chemotherapy
Cattel, L., Ceruti, M., & Dosio, F. (2004) · Journal of Chemotherapy · doi:10.1179/joc.2004.16.supplement-1.94 · Cited by 117
Ribba, B., Saut, O., Colin, T., Bresch, D., Grenier, E., & Boissel, J. (2006) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2006.07.013 · Cited by 117
Polyelectrolyte Complexes Stabilize and Controllably Release Vascular Endothelial Growth Factor
Huang, M., Vitharana, S. N., Peek, L. J., Coop, T., & Berkland, C. J. (2007) · Biomacromolecules · doi:10.1021/bm061211k · Cited by 116
Ramaekers, F., & Bosman, F. (2004) · Journal of Pathology · doi:10.1002/path.1665 · Cited by 116
Factors Affecting Drug and Gene Delivery: Effects of Interaction with Blood Components
Hashida, M., Opanasopit, P., & Nishikawa, M. (2002) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v19.i3.10 · Cited by 115
Monomolecular DNA Nanoparticles for Intravenous Delivery of Genes
Chandrashekhar, C., Zammut‐Italiano, L., Zuber, G., & Behr, J. (2005) · Journal of the American Chemical Society · doi:10.1021/ja0522332 · Cited by 115
Intracellular Delivery of Nanometric DNA Particles via the Folate Receptor
Dauty, E., Rémy, J.-S., Zuber, G., & Behr, J. (2002) · Bioconjugate Chemistry · doi:10.1021/bc0255182 · Cited by 113
Mauro Ferrari, B. (2005) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2005.06.001 · Cited by 113
Multifunctional Nanoparticulate Polyelectrolyte Complexes
Hartig, S. M., Greene, R. R., Dasgupta, J., Carlesso, G., Dikov, M. M., Prokop, A., & Davidson, J. M. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9623-2 · Cited by 113
Self-citationLiang, H., Yang, T.-F., Huang, C.-T., Chen, M., & Sung, H. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.03.021 · Cited by 112
John, T. A., Vogel, S. M., Minshall, R. D., Ridge, K. M., Tiruppathì, C., & Malik, A. B. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.0547a.x · Cited by 112
Oishi, M., Nagatsugi, F., Sasaki, S., Nagasaki, Y., & Kataoka, K. (2005) · ChemBioChem · doi:10.1002/cbic.200400334 · Cited by 111
Hitting multiple targets with multimeric ligands
Handl, H. L., Vágner, J., Han, H., Mash, E. A., Hruby, V. J., & Gillies, R. J. (2004) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.8.6.565 · Cited by 111
Konno, T., Kurita, K., Iwasaki, Y., Nakabayashi, N., & Ishihara, K. (2001) · Biomaterials · doi:10.1016/s0142-9612(00)00373-2 · Cited by 110
Modeling of the time-dependency of in vitro drug cytotoxicity and resistance.
Levasseur, L. M., Slocum, H. K., Rustum, Y. M., & Greco, W. R. (1998) · PubMed · Cited by 109
Targeting tumor angiogenesis: comparison of peptide and polymer-peptide conjugates.
Line, B. R., Mitra, A., Nan, A., & Ghandehari, H. (2005) · PubMed · Cited by 108
Cellular Fate of a Modular DNA Delivery System Mediated by Silica Nanoparticles
Gemeinhart, R. A., Luo, D., & Saltzman, W. M. (2005) · Biotechnology Progress · doi:10.1021/bp049648w · Cited by 108
Mathematical model for the cancer stem cell hypothesis
Ganguly, R., & Puri, I. K. (2006) · Cell Proliferation · doi:10.1111/j.1365-2184.2006.00369.x · Cited by 107
Khalil, I. G., & Hill, C. (2005) · Current Opinion in Oncology · doi:10.1097/01.cco.0000150951.38222.16 · Cited by 106
The Potential Role of Proteoglycans in Cationic Lipid-mediated Gene Delivery
Wiethoff, C. M., Smith, J. G., Koe, G. S., & Middaugh, C. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007940200 · Cited by 105
Haynie, D. T., Zhang, L., Rudra, J. S., Zhao, W., Yang, Z., & Palath, N. (2005) · Biomacromolecules · doi:10.1021/bm050525p · Cited by 105
Papin, J. A., & Palsson, B. Ø. (2004) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2003.11.016 · Cited by 104
Transferrin coupled liposomes as drug delivery carriers for brain targeting of 5-florouracil
Soni, V., Kohli, D. V., & Jain, S. K. (2005) · Journal of drug targeting · doi:10.1080/10611860500107401 · Cited by 103
The Effective Dispersion of Nanovectors Within the Tumor Microvasculature
Decuzzi, P., Causa, F., Mauro Ferrari, B., & Netti, P. A. (2006) · Annals of Biomedical Engineering · doi:10.1007/s10439-005-9072-6 · Cited by 102
Fusogenic liposome delivers encapsulated nanoparticles for cytosolic controlled gene release
Kunisawa, J., Masuda, T., Katayama, K., Yoshikawa, T., Tsutsumi, Y. M., Akashi, M., Mayumi, T., & Nakagawa, S. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.03.020 · Cited by 102
The application of systems biology to drug discovery
Cho, C. R., Labow, M., Reinhardt, M., van Oostrum, J., & Peitsch, M. C. (2006) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2006.06.025 · Cited by 101
New Technologies and Directed Agents for Applications of Cancer Imaging
Atri, M. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.6159 · Cited by 100
Bringing nanomedicines to market: regulatory challenges, opportunities, and uncertainties
Nijhara, R., & Balakrishnan, K. (2006) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2006.04.005 · Cited by 100
Assessing responses to cancer therapy using molecular imaging
Neves, A., & Brindle, K. M. (2006) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.10.002 · Cited by 100
Lipoplex size determines lipofection efficiency with or without serum
Almofti, M. R., Harashima, H., Shinohara, Y., Almofti, A., Li, W., & Kiwada, H. (2003) · Molecular Membrane Biology · doi:10.1080/09687680210035104 · Cited by 98
Simulating the Hallmarks of Cancer
Abbott, R. G., Forrest, S., & Pienta, K. J. (2006) · Artificial Life · doi:10.1162/artl.2006.12.4.617 · Cited by 97
Sinek, J. P., Frieboes, H. B., Zheng, X., & Vittorio Cristini, C. (2004) · Biomedical Microdevices · doi:10.1023/b:bmmd.0000048562.29657.64 · Cited by 95
A mathematical model of combination therapy using the EGFR signaling network
Araujo, R. P., Petricoin, E. F., & Liotta, L. A. (2004) · Biosystems · doi:10.1016/j.biosystems.2004.10.002 · Cited by 95
André, J. P., Geraldes, C. F. G. C., Martins, J. A., Merbach, A. E., Prata, M. I. M., SANTOS, A. C. D. S., de Lima, J. J. P., & Tóth, É. (2004) · Chemistry - A European Journal · doi:10.1002/chem.200400187 · Cited by 95
Ahmed, A., & Gohlke, H. (2006) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.20907 · Cited by 95
Folate targeting of drug carriers: A mathematical model
Ghaghada, K. B., Saul, J. M., Natarajan, J. V., Bellamkonda, R. V., & Annapragada, A. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.01.012 · Cited by 94
Krauze, M. T., McKnight, T. R., Yamashita, Y., Bringas, J., Noble, C. O., Saito, R., Geletneky, K., Forsayeth, J., Berger, M. S., Jackson, P., et al. (2005) · Brain Research Protocols · doi:10.1016/j.brainresprot.2005.08.003 · Cited by 94
In vivo distribution and antitumor activity of heparin-stabilized doxorubicin-loaded liposomes
Han, H., LEE, A., SONG, C., HWANG, T., Seong, H., Lee, C.-L., & SHIN, B. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.02.007 · Cited by 93
Managit, C., Kawakami, S., Yamashita, F., & Hashida, M. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20443 · Cited by 93
Transcellular Delivery of an Insulin-Transferrin Conjugate in Enterocyte-like Caco-2 Cells
Shah, D., & Shen, W. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js9601400 · Cited by 92
Kircheis, R., Ostermann, E., Wolschek, M. F., Lichtenberger, C., Magin-Lachmann, C., Wightman, L., Kursa, M., & Wagner, E. (2002) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700487 · Cited by 90
Frictional properties of poly(MPC-co-BMA) phospholipid polymer for catheter applications
Ho, S. P., Nakabayashi, N., Iwasaki, Y., Boland, T., & LaBerge, M. (2003) · Biomaterials · doi:10.1016/s0142-9612(03)00450-2 · Cited by 90
Juillerat‐Jeanneret, L., & Schmitt, F. (2006) · Medicinal Research Reviews · doi:10.1002/med.20086 · Cited by 90
Biodegradable nanoparticle delivery of a Th2-biased peptide for induction of Th1 immune responses
Lutsiak, M. E. C., Kwon, G. S., & Samuel, J. (2006) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.58.6.0004 · Cited by 89
Mahmud, A., & Lavasanifar, A. (2005) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2005.07.008 · Cited by 88
Kobayashi, H., Kawamoto, S., Saga, T., Sato, N., Hiraga, A., Konishi, J., Togashi, K., & Brechbiel, M. W. (2001) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.10025 · Cited by 88
Long‐circulating liposomal contrast agents for magnetic resonance imaging
Ayyagari, A. L., Zhang, X., Ghaghada, K. B., Annapragada, A., Hu, X. P., & Bellamkonda, R. V. (2006) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20846 · Cited by 87
Lin, J. J., Silas, J. A., Bermudez, H., Milam, V. T., Bates, F. S., & Hammer, D. A. (2004) · Langmuir · doi:10.1021/la036417a · Cited by 87
Quantitative elementary mode analysis of metabolic pathways: the example of yeast glycolysis
Schwartz, J., & Kanehisa, M. I. (2006) · BMC Bioinformatics · doi:10.1186/1471-2105-7-186 · Cited by 86
A sterically stabilized immunolipoplex for systemic administration of a therapeutic gene
Yu, W. H., Pirollo, K. F., Rait, A. S., Yu, B., Xiang, L., Huang, W.-Q., Zhou, Q., Ertem, G., & Chang, E. H. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302304 · Cited by 86
Preparation, purification and morphology of polymeric nanoparticles as drug carriers
Venier‐Julienne, M., & Benoît, J. (1996) · Pharmaceutica Acta Helvetiae · doi:10.1016/0031-6865(95)00059-3 · Cited by 84
Molecular targeting of angiogenesis
Alessi, P., Ebbinghaus, C., & Neri, D. (2003) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2003.08.001 · Cited by 84
Scavenger Receptor BI Transfers Major Lipoprotein-associated Phospholipids into the Cells
Urban, S., Zieseniss, S., Werder, M., Hauser, H., Budzinski, R., & Engelmann, B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004031200 · Cited by 83
Targeting Intracellular Targets
Panyam, J., & Labhasetwar, V. D. (2004) · Current Drug Delivery · doi:10.2174/1567201043334768 · Cited by 82
Tachibana, R., Harashima, H., Shono, M., Azumano, M., Niwa, M., Futaki, S., & Kiwada, H. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9460 · Cited by 82
Data‐Driven Computer Simulation of Human Cancer Cell
CHRISTOPHER, R., Dhiman, A., Fox, J. J., Gendelman, R., HABERITCHER, T., KAGLE, D., Spizz, G., Khalil, I. G., & HILL, C. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1310.014 · Cited by 81
Oyewumi, M. O., & Mumper, R. J. (2002) · Bioconjugate Chemistry · doi:10.1021/bc025560x · Cited by 80
Novel non-endocytic delivery of antisense oligonucleotides
Dokka, S., & Rojanasakul, Y. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00082-x · Cited by 80
Anti-MUC-1 immunoliposomal doxorubicin in the treatment of murine models of metastatic breast cancer
Moase, E. H., Qi, W., Ishida, T., Gabos, Z., Longenecker, B. M., Zimmermann, G., Ding, L., Krantz, M. J., & Allen, T. M. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(00)00334-5 · Cited by 80
Ala‐aho, R., Ahonen, M., George, S. J., Heikkilä, J., Grenman, R. A., Kallajoki, M. A., & Kähäri, V. (2004) · Oncogene · doi:10.1038/sj.onc.1207678 · Cited by 79
Zhao, B. N., Li, Y., Buono, C., Waldo, S. W., Jones, N. L., Mori, M., & Kruth, H. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510714200 · Cited by 79
Regulatory role of dynamin‐2 in VEGFR‐2/KDR‐mediated endothelial signaling
Bhattacharya, R., Kang, N., Hughes, D. A., Mukherjee, P., Shah, V. H., McNiven, M. A., & Mukhopadhyay, D. (2005) · The FASEB Journal · doi:10.1096/fj.05-3889fje · Cited by 78
Monck, M. A., Mori, A., Lee, D., Tam, P., Wheeler, J. J., Cullis, P. R., & Scherrer, P. (2000) · Journal of drug targeting · doi:10.3109/10611860009102218 · Cited by 78
Biomarkers, Validation and Pharmacokinetic-Pharmacodynamic Modelling
Colburn, W. A., & Lee, J. W. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342120-00001 · Cited by 76
Theoretical Predictions of Drug Absorption in Drug Discovery and Development
Stenberg, P., m, C. A. S. B., Luthman, K., & Artursson, P. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241110-00005 · Cited by 75
Unusual Salt Stability in Highly Charged Diblock Co-polypeptide Hydrogels
Nowak, A. P., Breedveld, V., Pine, D. J., & Deming, T. J. (2003) · Journal of the American Chemical Society · doi:10.1021/ja0381050 · Cited by 74
Bendas, G. (2001) · BioDrugs · doi:10.2165/00063030-200115040-00002 · Cited by 74
Nanoscale polymer carriers to deliver chemotherapeutic agents to tumours
Cegnar, M., Kristl, J., & Kos, J. (2005) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.5.12.1557 · Cited by 73
Efficacy of immunoliposomes on cancer models in a cell-surface-antigen-density-dependent manner
Hosokawa, S., Tagawa, T., Niki, H., Hirakawa, Y., Nohga, K., & Nagaike, K. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601341 · Cited by 72
Endocytosis of lipid rafts: an identity crisis
Sharma, P., Sabharanjak, S., & Mayor, S. (2002) · Seminars in Cell and Developmental Biology · doi:10.1016/s1084-9521(02)00049-6 · Cited by 71
A Long-Circulating co-Polymer in “Passive Targeting” to Solid Tumors
Bogdanov, A. A., Jr., Wright, S., Marecos, E., et al. (1997) · Journal of drug targeting · doi:10.3109/10611869708995848 · Cited by 71
Voisin, P. J., Ribot, E. J., Miraux, S., Bouzier‐Sore, A., Lahitte, J., Bouchaud, V., Mornet, S., Thiaudière, E., Franconi, J., Raison, L., et al. (2007) · Bioconjugate Chemistry · doi:10.1021/bc060269t · Cited by 70
Bergey, E. J., Lévy, L., Wang, X., Krebs, L. J., Lal, M., Kim, K.-S., Pakatchi, S., Liebow, C., & Prasad, P. N. (2002) · Biomedical Microdevices · doi:10.1023/a:1020906307053 · Cited by 67
Némati, F. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(96)04559-0 · Cited by 67
Moghimi, S. M., & Rajabi‐Siahboomi, A. R. (1996) · Progress in Biophysics and Molecular Biology · doi:10.1016/s0079-6107(96)00012-0 · Cited by 67
Development of carbonyl iron/ethylcellulose core/shell nanoparticles for biomedical applications
Arias, J. L., López-Viota, M., Ruíz, M. A., López-Viota, M., & Delgado, Á. V. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.02.028 · Cited by 65
Targeting the tumor vascular compartment to improve conventional cancer therapy
Féron, O. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.08.008 · Cited by 64
Fischer, H. (2005) · Biotechnology annual review · doi:10.1016/s1387-2656(05)11001-1 · Cited by 63
McLoughlin, J. M., McCarty, T. M., Cunningham, C. C., Clark, V., Senzer, N. N., Nemunaitis, J. J., & Kuhn, J. A. (2005) · Annals of Surgical Oncology · doi:10.1245/aso.2005.03.023 · Cited by 63
A two-tiered physiologically based model for dually labeled single-chain Fv-Fc antibody fragments
Ferl, G. Z., Kenanova, V. E., Wu, A. M., & DiStefano, J. J. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0072 · Cited by 62
Zhang, J., Fredin, N. J., Janz, J. F., Sun, B. X., & Lynn, D. M. (2005) · Langmuir · doi:10.1021/la052360b · Cited by 62
Šťastný, M., Strohalm, J., Plocová, D., Ulbrich, K., & Řı́hová, B. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00373-6 · Cited by 61
Imaging brain tumors by targeting peptide radiopharmaceuticals through the blood-brain barrier.
Kurihara, A., & Pardridge, W. M. (1999) · PubMed · Cited by 61
Prokop, A., Kozlov, E., Carlesso, G., & Davidson, J. M. (2002) · Advances in polymer science · doi:10.1007/3-540-45362-8_3 · Cited by 61
Self-citationHaas, J., Kumar, M. N. V. R., Borchard, G., Bakowsky, U., & Lehr, C. (2005) · AAPS PharmSciTech · doi:10.1208/pt060106 · Cited by 60
Zelikin, A. N., Trukhanova, E. S., Putnam, D. A., et al. (2003) · Journal of the American Chemical Society · doi:10.1021/ja036387y · Cited by 59
Role of efflux pumps and metabolising enzymes in drug delivery
Katragadda, S., Budda, B., Anand, B. S., & Mitra, A. K. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2.4.683 · Cited by 58
Manunta, M., Nichols, B. J., Tan, P., Sagoo, P., Harper, J., & George, A. J. T. (2006) · Journal of Immunological Methods · doi:10.1016/j.jim.2006.06.007 · Cited by 58
Cited by
PLGA-based nanoparticles: An overview of biomedical applications
Danhier, F., Ansorena, E., Silva, J. M., Coco, R., Le Breton, A., & Préat, V. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.043 · Cited by 3,806
Applications of nanoparticle systems in drug delivery technology
Rizvi, S. A. A., & Saleh, A. M. (2018) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2017.10.012 · Cited by 1,334
Nanoparticles for Cancer Therapy: Current Progress and Challenges
Gavas, S., Quazi, S., & Karpiński, T. M. (2021) · Nanoscale Research Letters · doi:10.1186/s11671-021-03628-6 · Cited by 1,069
Mesoporous Silica Nanoparticles for Intracellular Controlled Drug Delivery
Vivero‐Escoto, J. L., Slowing, I. I., Trewyn, B. G., & Lin, V. S. ‐. (2010) · Small · doi:10.1002/smll.200901789 · Cited by 998
RGD-Based Strategies To Target Alpha(v) Beta(3) Integrin in Cancer Therapy and Diagnosis
Danhier, F., Le Breton, A., & Préat, V. (2012) · Molecular Pharmaceutics · doi:10.1021/mp3002733 · Cited by 955
Metadata
- Authors
- Prokop, A., & Davidson, J. M.
- Venue
- Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2008-09
- Volume
- 97
- Issue
- 9
- Pages
- 3518-3590
- ISSN
- 0022-3549 (ISSN-L)
- OpenAlex
- W2102819518
- Cited by
- 363
- References
- 466
- FWCI
- 4.39
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.